How pharmacists are helping to push vital health efforts.
The PBM giant is cutting down on the number of opioids new patients can buy.
The settlement is the end of a long legal battle.
When drug prices spike, health-care providers are forced to make tough choices.
FDA is alerting health professionals to a sterility breach with Vital Rx Inc. products.
New research suggests that the latest trend in opioids may not be so helpful.
The recall affects a variety of distributors.
Here's the technology your pharmacy might have in the next 10 years.
The agency says that the reduction lines up with current demand for opioids.
How the FDA is prioritizing drugs that offer the biggest health gains.